Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
An MJFF-funded Phase IIb placebo-controlled trial did show mild benefit but because the placebo group also improved, the significance of these results is unclear
Long-Term Protocols: The most clinically relevant studies evaluated subcutaneous doses of 0.25 mg (250 mcg), 0.5 mg (500 mcg), and 1 mg (1,000 mcg) administered daily for 24 weeks
[PMID: 5871837] PubMed record related to this compound for laboratory literature review
These are reference figures, not approved human dosing
An initial consultation and assessment of your B12 status
US$ 29.64
US$ 24.61
US$ 24.61
US$ 27.59
